{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:45:20Z","timestamp":1790095520081,"version":"4.0.1"},"reference-count":19,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["headachejournal.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Headache"],"published-print":{"date-parts":[[2022,11]]},"abstract":"Abstract<\/jats:title>\n \n Objective<\/jats:title>\n We investigated whether telephone follow\u2010up consultations could lead to appropriate adjustment of treatments and a higher degree of patient satisfaction among patients with migraine and tension\u2010type headache (TTH).<\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Migraine and TTH are disabling headache forms requiring optimized treatment.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In a prospective, non\u2010randomized, quality control study with controls comparing telephone\u2010interview intervention (TeII) with business\u2010as\u2010usual (BAU) treatment, we included newly referred patients with migraine and\/or TTH. The TeII group was contacted by telephone by healthcare professionals at 8 and 16\u2009weeks after the first visit addressing headache treatment. Electronic questionnaires were sent to all participants before the first visit and after 6\u2009months. Predefined outcomes were number of patients with change in preventive and acute medication; change in headache frequency; migraine frequency; scores from the eight\u2010item Headache Under\u2010Response to Treatment (HURT\u20108) questionnaire, Insomnia Severity Index (ISI), and Hospital Anxiety and Depression Scale (HADS); and patient satisfaction after 6\u2009months.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n From May 2020 to April 2021, there were 230 patients enrolled in the TeII program, whereof 96 patients were included in the analysis. For the BAU group, 91 patients with similar sex and age distribution were identified via medical\u2010record reviews in the same period. More patients in the TeII group than in the BAU group had a change in acute medication (27\/96 [28%] vs. five of 91 [6%],\n p<\/jats:italic>\n \u2009<\u20090.001) and preventive medication (28\/96 [29%] vs. 12\/91 [13%],\n p<\/jats:italic>\n \u00a0=\u00a00.006). Headache days per month decreased in the TeII group (\u22124.6, 95% confidence interval [CI] \u22126.5 to \u22122.7;\n p<\/jats:italic>\n \u00a0=\u00a00.001) and the BAU group (\u22122.5, 95% CI \u22124.6 to \u22120.4;\n p<\/jats:italic>\n \u00a0=\u00a00.018), without significant difference between the groups (\n p<\/jats:italic>\n \u00a0=\u00a00.080). There was no difference in migraine frequency between the groups (TeII: 1.0\u2009day, 95% CI, \u22121.3 to 1.0; BAU: 1.0\u2009day, 95% CI, \u22122.5 to 0.5;\n p<\/jats:italic>\n \u00a0=\u00a00.718) or HURT\u20108 score (TeII: 10.5, 95% CI 9.5\u201311.5; BAU: 13.0, 95% CI 11.7\u201314.2;\n p<\/jats:italic>\n \u00a0=\u00a00.053). There were no changes in the ISI score (TeII: 1.0, interquartile range [IQR] 6;\n p<\/jats:italic>\n \u00a0=\u00a00.152; BAU: 0.5, IQR 4.5;\n p<\/jats:italic>\n \u00a0=\u00a00.824), HADS\u2010Anxiety score (TeII: \u22125, IQR 5.3;\n p<\/jats:italic>\n \u00a0=\u00a00.186; BAU: 1.0, IQR 4.0;\n p<\/jats:italic>\n \u00a0=\u00a00.445), or HADS\u2010Depression score (TeII: 0.0, IQR 3.0;\n p<\/jats:italic>\n \u00a0=\u00a00.163; BAU: 0.0, IQR 2.0;\n p<\/jats:italic>\n \u00a0=\u00a00.303) in any of the groups. There was a higher degree of patient satisfaction in the TeII group compared with the BAU group in treatment (median [IQR] score 4 [3\u20135] vs. 3\u00a0[3\u20134],\n p<\/jats:italic>\n \u2009<\u20090.001), headache improvement (median [IQR] 3\u00a0[2\u20134] vs. 2\u00a0[1\u20133],\n p<\/jats:italic>\n \u00a0=\u00a00.002), the headache program (median [IQR] 4\u00a0[3\u20135] vs. 3\u00a0[3\u20134],\n p<\/jats:italic>\n \u2009<\u20090.001), and information (median [IQR] 4\u00a0[3\u20135] vs. 3\u00a0[3\u20134],\n p<\/jats:italic>\n \u00a0=\u00a00.005).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Patients with migraine and\/or TTH benefit from a telephone follow\u2010up approach within the first 6\u2009months of their treatment course in terms of more efficient treatment and higher patient satisfaction.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/head.14405","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T06:51:43Z","timestamp":1668408703000},"page":"1312-1321","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Telephone follow\u2010up on treatment and patient satisfaction at a Danish tertiary headache center: A prospective study"],"prefix":"10.1111","volume":"62","author":[{"given":"Louise Ninett","family":"Carlsen","sequence":"first","affiliation":[{"name":"Danish Headache Center, Neurological Department University of Copenhagen, Rigshospitalet \u2013 Glostrup Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bendtsen","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Neurological Department University of Copenhagen, Rigshospitalet \u2013 Glostrup Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigmor H\u00f8jland","family":"Jensen","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Neurological Department University of Copenhagen, Rigshospitalet \u2013 Glostrup Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Winther","family":"Schytz","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Neurological Department University of Copenhagen, Rigshospitalet \u2013 Glostrup Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00257-2"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32160-7"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00509-5"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-011-0320-x"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-020-00205-4"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12055"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414547138"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13178"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.057968"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.446002.x"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415583146"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0842-6"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(00)00065-4"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13098"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1500"},{"key":"e_1_2_10_18_1","volume-title":"Botulinum Toxin Type A for the Prevention of Headaches in Adults With Chronic Migraine","author":"NICE Guidelines","year":"2021"},{"key":"e_1_2_10_19_1","volume-title":"Erenumab for Preventing Migraine","author":"NICE Guidelines","year":"2021"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-011-0348-y"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14405","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/head.14405","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:08:00Z","timestamp":1762078080000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.14405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1111\/head.14405"],"URL":"https:\/\/doi.org\/10.1111\/head.14405","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"2022-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}